91 data-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "Dr" "UCL" PhD scholarships at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
elucidation and (bio-)chemical methods, interconnecting biochemistry, pharmacology, and medicine and foster the individual development of young researchers. Further information: https://www.medizin.uni
-
the reference number 27697, via our online portal: Apply now via https://jobs.uksh.de/job/Kiel-PhD-%28mfd%29-Statistical-Genetics-Machine-Learning-Schl-24105/1279933701/ For more information visit: www.uksh.de
-
collection of original survey data - Development and implementation of experimental studies - Writing and contributing to scientific papers for peer review - Presentation of findings at national and
-
Information about union representatives, see Help for applicants . Application procedure Apply via LiUs webpage for vacancies, https://liu.se/en/work-at-liu/vacancies/28629 . Your application must reach
-
project’s principal investigator, Associate Professor Lars Rohwedder, an internationally recognized expert in the areas of approximation algorithms and parameterized algorithms, see https://larsrohwedder.com
-
development and scientific outreach. Please visit https://www.cancer.dk/danish-cancer-institute/ for more information. We wish to reflect the diversity of society and encourage all qualified candidates
-
qualified candidates, regardless of background, to apply. About the position The position is available from May 1st 2026, but both a later and earlier startup date is possible. Dr. Håvard Lindholm is
-
for which your data will be processed, as well as further information about data protection is available to you on the website: https://tu-dresden.de/karriere/datenschutzhinweis .
-
, the purpose for which your data will be processed, as well as further information about data protection is available to you on the website: https://tu-dresden.de/karriere/datenschutzhinweis .
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed